Unpleasant taste is the biggest barrier for completing treatment in pediatrics and 30% to 40% of parents had children who rejected or refused a pill or liquid medication. 26% of geriatric patients reported difficulty swallowing tablets and capsules.
By applying a taste masking application, patient compliance can increase 53% to 90%. The correlation between taste masking and understanding the impact to patient adherence is critical for any successful treatment plan. In this 4-part webinar series, we will discuss: the challenges within the industry such as swallowability and palatability related to patient acceptability for oral drug formulations; Regulatory and critical insights for developing a taste masked therapeutic, and an overview of taste masking strategies and techniques. In future segments of the series, innovations regarding sensory and performance and evaluation will be discussed.
In the second webinar of this series, you will learn about key product parameters affecting patient acceptability and therapy adherence, and taste masking strategies applied including excipients, organoleptic and barrier coating approaches and microencapsulation technologies. Learn how these applications optimize product development and can improve patient adherence and ultimately improve patient outcomes. Register to learn how to improve your products today.
Dr. Boltri is a pharmaceutical chemist by training and completed his degree at the University of Turin.
With more than 30 years of experience in the Pharmaceutical Industry, Dr Boltri has held leading positions as Department Head and Director. Dr. Boltri has extensive experience in formulation development for various dosage forms, with a focus on oral delivery and bioavailability enhancement.
In the current role, Dr. Boltri supports Company processes leading to identify new and innovative technologies as well as valuable opportunities for product development and co-development.
Dr. Nasrin Mahmoudi,
Technical Manager, International Flavors and Fragrances (IFF) company
Nasrin is a member of the Application Development and Innovation (AD&I) team within Pharma Solutions business division of the International Flavors and Fragrances (IFF) company. As a scientist and technical manager, Nasrin’s role is working with the pharmaceutical customers in the North American region to partner in product development. Nasrin provides technical information on application/regulatory aspects of the broad range of excipients and enables customers to troubleshoot and facilitate their formulation development process. Nasrin has PharmD and Ph.D. degrees from the Medical Sciences University of Tehran (Iran) followed by post-doctoral research at Rutgers University (NJ, US) and Pfizer Inc (NJ, & MI, US). Nasrin has a broad range of experiences in the pharmaceutical industry, particularly in solubility enhancement, immediate and controlled release dosage forms and taste masking of oral formulations.
Key Learning Objectives
Identify and analyse the key product parameters affecting patient acceptability and therapy adherence
Deeper understanding of selected taste-masking and patient-centric strategies including the importance of functional excipients, organoleptic and barrier coating approaches, as well as (micro) encapsulation technologies.
Learn through case studies, how these applications optimize product development, improve patient adherence, and ultimately improve patient outcomes.